NCT05321472

Brief Summary

Common bile duct stenosis is an important indication for endoscopic retrograde cholangiopancreatography(ERCP). Appropriate selection of bile duct stent size is not only conducive to successful stent implantation but also to improve the prognosis of patients. Currently, the selection of stent specifications is based on the operator's empirical estimation, which is not only not accurate but also increases the radiation exposure time, causing unnecessary harm to both the operator and the patient. Our objective is to develop an artificial intelligence algorithm to automatically select appropriate stent.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
600

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 3, 2022

Completed
8 days until next milestone

First Posted

Study publicly available on registry

April 11, 2022

Completed
9 days until next milestone

Study Start

First participant enrolled

April 20, 2022

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2022

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2023

Completed
Last Updated

July 6, 2022

Status Verified

May 1, 2022

Enrollment Period

3 months

First QC Date

April 3, 2022

Last Update Submit

July 2, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • The accuracy of the calculated length of the stents by the artificial intelligence

    The length of the stent was calculated "the length from the stenosis to the papilla+2cm".The length of the stent selected by experts is the gold standard

    6 months

Secondary Outcomes (1)

  • The accuracy of the segmentation of the artificial intelligence

    4 months

Study Arms (2)

group for training the algorithm

This group of images is used for training the algorithm of the artificial intelligence

group for testing the algorithm

This group of images is used for testing the algorithm of the artificial intelligence

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The eligible images was randomly devided into two groups. One group for training the algorithm and the other group for testing the algorithm.

You may qualify if:

  • Patients older than 18 years old who underwent ERCP

You may not qualify if:

  • failed cholangiopancreatography caused by failed intubation, gastric retention, duodenal disease and so on
  • patients proved no stenosis in common bile duct
  • poor cholangiograms due to the lack of contrast agent or insufficient filling of contrast agent (cholangiograms without the completed CBD or thumbnails)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Gastroenterology,QiLu Hospital,Shandong University

Jinan, Shandong, 250012, China

RECRUITING

Related Publications (2)

  • Adler DG, Lieb JG 2nd, Cohen J, Pike IM, Park WG, Rizk MK, Sawhney MS, Scheiman JM, Shaheen NJ, Sherman S, Wani S. Quality indicators for ERCP. Gastrointest Endosc. 2015 Jan;81(1):54-66. doi: 10.1016/j.gie.2014.07.056. Epub 2014 Dec 2. No abstract available.

    PMID: 25480099BACKGROUND
  • Huang L, Lu X, Huang X, Zou X, Wu L, Zhou Z, Wu D, Tang D, Chen D, Wan X, Zhu Z, Deng T, Shen L, Liu J, Zhu Y, Gong D, Chen D, Zhong Y, Liu F, Yu H. Intelligent difficulty scoring and assistance system for endoscopic extraction of common bile duct stones based on deep learning: multicenter study. Endoscopy. 2021 May;53(5):491-498. doi: 10.1055/a-1244-5698. Epub 2020 Nov 9.

    PMID: 32838430BACKGROUND

Study Officials

  • Yanqing Li, MD, PhD

    Qilu Hospital of Shandong University

    STUDY CHAIR

Central Study Contacts

Yanqing Li, MD, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Vice President of Qilu Hospital

Study Record Dates

First Submitted

April 3, 2022

First Posted

April 11, 2022

Study Start

April 20, 2022

Primary Completion

August 1, 2022

Study Completion

April 1, 2023

Last Updated

July 6, 2022

Record last verified: 2022-05

Locations